IL160894A0 - Combination of selected opioids with muscarine antagonists for treating urinary incontinence - Google Patents
Combination of selected opioids with muscarine antagonists for treating urinary incontinenceInfo
- Publication number
- IL160894A0 IL160894A0 IL16089402A IL16089402A IL160894A0 IL 160894 A0 IL160894 A0 IL 160894A0 IL 16089402 A IL16089402 A IL 16089402A IL 16089402 A IL16089402 A IL 16089402A IL 160894 A0 IL160894 A0 IL 160894A0
- Authority
- IL
- Israel
- Prior art keywords
- urinary incontinence
- combination
- treating urinary
- opioids
- muscarine antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10146275A DE10146275A1 (de) | 2001-09-18 | 2001-09-18 | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
PCT/EP2002/010460 WO2003024444A1 (de) | 2001-09-18 | 2002-09-18 | Kombination ausgewählter opioide mit muscarin-antagonisten zur therapie der harninkontinenz |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160894A0 true IL160894A0 (en) | 2004-08-31 |
Family
ID=7699618
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16089402A IL160894A0 (en) | 2001-09-18 | 2002-09-18 | Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
IL160894A IL160894A (en) | 2001-09-18 | 2004-03-16 | Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL160894A IL160894A (en) | 2001-09-18 | 2004-03-16 | Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
Country Status (22)
Country | Link |
---|---|
US (2) | US20040242617A1 (no) |
EP (1) | EP1429754B1 (no) |
JP (1) | JP4511176B2 (no) |
KR (1) | KR100891438B1 (no) |
CN (1) | CN100384413C (no) |
AT (1) | ATE383854T1 (no) |
AU (1) | AU2002342707B2 (no) |
BR (1) | BR0212714A (no) |
CA (1) | CA2460655C (no) |
DE (2) | DE10146275A1 (no) |
EC (1) | ECSP045025A (no) |
ES (1) | ES2299608T3 (no) |
HK (1) | HK1075205A1 (no) |
HU (1) | HUP0401485A3 (no) |
IL (2) | IL160894A0 (no) |
MX (1) | MXPA04002510A (no) |
NO (1) | NO333016B1 (no) |
NZ (1) | NZ531777A (no) |
PL (1) | PL209272B1 (no) |
RU (1) | RU2305562C2 (no) |
WO (1) | WO2003024444A1 (no) |
ZA (1) | ZA200402853B (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10146275A1 (de) | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
US7410965B2 (en) | 2002-05-29 | 2008-08-12 | Gruenenthal Gmbh | Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol |
DE10224108A1 (de) * | 2002-05-29 | 2004-01-29 | Grünenthal GmbH | 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung |
DE10224556A1 (de) * | 2002-05-31 | 2004-01-08 | Grünenthal GmbH | 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen |
CA2510292A1 (en) * | 2002-12-20 | 2004-07-15 | Dynogen Pharmaceuticals, Inc. | Methods of treating non-painful bladder disorders using .alpha.2.delta. subunit calcium channel modulators |
US20040198822A1 (en) * | 2003-03-21 | 2004-10-07 | Dynogen Pharmacueticals, Inc. | Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators |
DE10356362A1 (de) * | 2003-11-28 | 2005-06-23 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen |
MXPA06013270A (es) * | 2004-05-14 | 2007-04-23 | Johnson & Johnson | Compuestos de opioide carboxamido. |
DE102005009217A1 (de) * | 2005-02-25 | 2006-08-31 | Grünenthal GmbH | Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen |
WO2007009794A1 (de) * | 2005-07-22 | 2007-01-25 | Grünenthal GmbH | Hcl-polymorphe von 3 - ( 2- (dimethylamino) methyl- ( cyclohex-i-yl) ) phenol |
US20070032551A1 (en) * | 2005-07-22 | 2007-02-08 | Gruenenthal Gmbh | Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof |
US7884247B2 (en) * | 2005-07-22 | 2011-02-08 | Gruenenthal Gmbh | Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof |
DE102007022790A1 (de) | 2007-05-11 | 2008-11-20 | Grünenthal GmbH | Axomadol zur Schmerzbehandlung bei Arthrose |
RU2673882C1 (ru) * | 2008-10-30 | 2018-12-03 | Грюненталь Гмбх | Новые и эффективные лекарственные формы тапентадола |
WO2011110595A1 (de) | 2010-03-10 | 2011-09-15 | Grünenthal GmbH | Kristalline salze und/oder cokristalle von o-desmethyltramadol |
SE1251371A1 (sv) | 2010-05-10 | 2012-12-27 | Euro Celtique Sa | Farmaceutiska kompositioner innefattande hydromorfon och naloxon |
JP5838199B2 (ja) | 2010-05-10 | 2016-01-06 | ユーロ−セルティーク エス.エイ. | 活性剤を含まない顆粒およびその顆粒を含む錠剤の製造 |
MX344846B (es) | 2010-05-10 | 2017-01-10 | Euro-Celtique S A * | Combinacion de granulos cargados activos con activos adicionales. |
CN103040828B (zh) * | 2013-01-07 | 2015-12-02 | 常州康普药业有限公司 | 复方地芬诺酯片及其制备方法 |
DE112014005175T5 (de) | 2013-11-13 | 2016-07-21 | Euro-Celtique S.A. | Hydromorphon und Naloxon für die Behandlung von Schmerzen und Opioid-Darm-Dysfunktions-Syndrom |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB857194A (en) * | 1957-07-05 | 1960-12-29 | Clinical Products Ltd | Therapeutic agents comprising ion-exchange resins |
NL127065C (no) | 1964-04-22 | |||
US5736577A (en) | 1995-01-31 | 1998-04-07 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
DE3012837A1 (de) * | 1979-04-10 | 1980-10-30 | Sandoz Ag | Analgetische und myotonolytische praeparate |
DE3129982A1 (de) * | 1981-07-29 | 1983-02-17 | Jutta 8200 Rosenheim Meyer | "antiallergikum" |
US5073560A (en) | 1990-07-20 | 1991-12-17 | Fisons Corporation | Spiro-isoxazolidine derivatives as cholinergic agents |
DE4041559A1 (de) | 1990-12-22 | 1992-06-25 | Boehringer Ingelheim Kg | Neue wirkstoffkombinationen |
DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
ATE259232T1 (de) * | 1995-03-03 | 2004-02-15 | Endo Pharmaceuticals Inc | Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz |
DE19525137C2 (de) | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
DE19609847A1 (de) * | 1996-03-13 | 1997-09-18 | Gruenenthal Gmbh | Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe |
JP2000515525A (ja) | 1996-07-19 | 2000-11-21 | アベーグ,グンナー | 尿と胃腸の疾患の治療におけるs(―)―トルテロジン |
US6090856A (en) * | 1997-04-11 | 2000-07-18 | Nippon Shinyaku Co., Ltd. | Remedies for frequent urination and urinary incontinence |
PE20010623A1 (es) | 1999-10-05 | 2001-07-07 | Gruenenthal Chemie | Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria |
JP2003523382A (ja) * | 2000-02-24 | 2003-08-05 | ファルマシア・アンド・アップジョン・カンパニー | 新規な薬物の組合せ |
DE10059412A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz |
DE10146275A1 (de) | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
-
2001
- 2001-09-18 DE DE10146275A patent/DE10146275A1/de not_active Withdrawn
-
2002
- 2002-09-18 RU RU2004111788/15A patent/RU2305562C2/ru not_active IP Right Cessation
- 2002-09-18 AU AU2002342707A patent/AU2002342707B2/en not_active Ceased
- 2002-09-18 DE DE50211566T patent/DE50211566D1/de not_active Expired - Lifetime
- 2002-09-18 BR BR0212714-8A patent/BR0212714A/pt not_active Application Discontinuation
- 2002-09-18 HU HU0401485A patent/HUP0401485A3/hu unknown
- 2002-09-18 EP EP02779368A patent/EP1429754B1/de not_active Expired - Lifetime
- 2002-09-18 ES ES02779368T patent/ES2299608T3/es not_active Expired - Lifetime
- 2002-09-18 JP JP2003528540A patent/JP4511176B2/ja not_active Expired - Fee Related
- 2002-09-18 IL IL16089402A patent/IL160894A0/xx unknown
- 2002-09-18 CN CNB028227794A patent/CN100384413C/zh not_active Expired - Fee Related
- 2002-09-18 PL PL369235A patent/PL209272B1/pl unknown
- 2002-09-18 WO PCT/EP2002/010460 patent/WO2003024444A1/de active IP Right Grant
- 2002-09-18 AT AT02779368T patent/ATE383854T1/de active
- 2002-09-18 MX MXPA04002510A patent/MXPA04002510A/es active IP Right Grant
- 2002-09-18 CA CA2460655A patent/CA2460655C/en not_active Expired - Fee Related
- 2002-09-18 NZ NZ531777A patent/NZ531777A/en not_active IP Right Cessation
- 2002-09-18 KR KR1020047004002A patent/KR100891438B1/ko not_active IP Right Cessation
-
2004
- 2004-03-12 NO NO20041059A patent/NO333016B1/no not_active IP Right Cessation
- 2004-03-16 IL IL160894A patent/IL160894A/en not_active IP Right Cessation
- 2004-03-17 EC EC2004005025A patent/ECSP045025A/es unknown
- 2004-03-18 US US10/803,187 patent/US20040242617A1/en not_active Abandoned
- 2004-04-15 ZA ZA2004/02853A patent/ZA200402853B/en unknown
-
2005
- 2005-08-29 HK HK05107560.0A patent/HK1075205A1/xx not_active IP Right Cessation
-
2011
- 2011-09-23 US US13/242,672 patent/US8946290B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1075205A1 (en) | Combination of selected opioids with muscarine antagonists for treating urinary incontinence | |
BR0114799A (pt) | Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos | |
WO2006066879A3 (en) | Compounds with kv4 ion channel activity | |
EP1933833B8 (en) | Therapy for the treatment of overactive bladder | |
DE60041976D1 (de) | Phenoxycarbonsäureverbindungen und zusammensetzungen zur verabreichung aktiver wirkstoffe | |
CA2366702A1 (en) | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents | |
EP2275107A3 (en) | Combinations for the treatment of diseases involving cell proliferation | |
YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
WO2006093348A3 (en) | Method and composition for treating peripheral vascular diseases | |
EA200800161A1 (ru) | Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций | |
MY125414A (en) | Aminopropylphosphinic acids | |
EP2767291A3 (en) | Treatment of glycogen storage disease type II | |
DE60134245D1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
GB0112348D0 (en) | Compounds | |
HK1047707A1 (zh) | (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途 | |
IL162384A0 (en) | Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases | |
TW200501963A (en) | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases | |
BR0315247A (pt) | Composição, composição farmacêutica, método de tratamento para uma doença proliferativa celular, e, kit | |
MXPA06007007A (es) | Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores. | |
AU2001246388A1 (en) | Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine | |
WO2002055022A3 (en) | Active metabolite of antifungal compound | |
IL156140A0 (en) | Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence | |
PT1337246E (pt) | Utilizacao de compostos de 6-dimetilaminometil-1-fenilciclohexano para terapia da incontinencia urinaria | |
ES2181407T3 (es) | Glucocorticoides para tratar la glomerulonefritis. | |
SE0100873D0 (sv) | Method of treatment |